Jamp Amoxi Clav Suspension recall in Canada: product quality issue
In plain language
This recall involves Jamp Amoxi Clav Suspension sold in Canada. It's being recalled because affected lots may have incorrect concentrations of active ingredients. Consult your healthcare provider before stopping use and follow the return/repair steps in the official notice.
What to do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use.
- Contact JAMP Pharma Corporation with any questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Jamp Amoxi Clav Suspension
Lot: E30369, E30370
Why this matters
Product quality issue
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: E30369, E30370
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Product quality issue
What should consumers do?
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use. Contact JAMP Pharma Corporation with any questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Product quality issue
When was this product recalled?
This product was recalled on December 23, 2024.
Is the Jamp Pharma brand affected by this recall?
Yes, Jamp Pharma products are affected by this recall. This recall involves Jamp Amoxi Clav Suspension sold in Canada. It's being recalled because affected lots may have incorrect concentrations of active ingredients. Consult your healthcare provider before stopping use and follow the return/repair steps in the official notice.